• A Case of Autoimmune Hepatitis Initially Manifesting as Hepatic Encephalopathy
• A real-world drug safety surveillance study of lenvatinib from the FAERS database
• A Retrospective Case Series Analysis of Pregnancy and COVID-19 Based on a Global Postmarketing COVID-19 Surveillance Program
• A Retrospective Cohort Study From the National Inpatient Sample Database (2016-2019): Does Obesity Affect the Outcomes of Hospitalization Due to Hepatocellular Carcinoma?
• Acquired chronic hepatocerebral degeneration (CAHD) - Simulation of parkinsonism, secondary to chronic liver disease
• Acute kidney injury in severe alcohol-associated hepatitis treated with anakinra plus zinc or prednisone
• Acute liver failure
• Acute liver failure: A practical update
• Acute liver failure: Management update and prognosis
• Acute presentation of autoimmune hepatitis -from acute hepatitis to ALF and ACLF
• Acute-on-chronic liver failure; prevalence, causes, predisposing factors, and outcome
• Advancements in Interventional Radiology for Managing Hepatic Encephalopathy: A Comprehensive Review
• Advances in Research on the Effectiveness and Mechanism of Active Ingredients from Traditional Chinese Medicine in Regulating Hepatic Stellate Cells Autophagy Against Hepatic Fibrosis
• Advances in the management of complications from cirrhosis
• Alcoholic Liver Disease in China: A Disease Influenced by Complex Social Factors That Should Not Be Neglected
• Artificial Intelligence Evaluation of Stool Quality Guides Management of Hepatic Encephalopathy Using a Smartphone App
• Assessment of gnostic and stereognostic functions in patients with liver cirrhosis: A comparative study with healthy controls
• Association of Acetaminophen (Paracetamol) Use with Severity and Outcomes in Patients with Viral Hepatitis-Associated Acute Liver Failure
• Bedside assessment of sarcopenia in hospitalized patients with liver cirrhosis: Magnitude and clinical implications
• Bibliometrics and knowledge mapping of the pathogenesis of hepatic encephalopathy in patients with liver cirrhosis
• Brain Lesions in Liver Cirrhosis May Not Only Be Due to Hepatic Encephalopathy
• Burden of Portal Hypertension Complications Is Greater in Liver Transplant Wait-Listed Registrants with End-Stage Liver Disease and Type 2 Diabetes
• Carvedilol to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by liver stiffness: study protocol for a randomied, double-blind, placebo-controlled, multicentre trial in China
• Case Report: Dengue Fever Progressing to Acute Liver Failure and Hepatic Encephalopathy
• Chinese guidelines on the management of ascites in cirrhosis : Chinese Society of Hepatology, Chinese Medical Association
• Clinical Implications and Management of Spontaneous Portosystemic Shunts in Liver Cirrhosis
• Clinical Profile and Outcome of Patients Presenting With Acute-on-Chronic Liver Failure: A Single-Center Experience
• Comparison Between Creatinine-Modified Pugh Score and Child-Pugh Score for Prognostication in Decompensated Cirrhosis
• Comparison of Endoscopic Ultrasound-guided Cyanoacrylate Injection and Transjugular Intrahepatic Portosystemic Shunt in the Prevention of Gastric Varices Rebleeding
• Current status of etiology and outcomes of acute liver failure in India-A multicentre study from tertiary centres
• Dengue and leptospirosis coinfection: a case series
• Detection of minimal hepatic encephalopathy in patients with cirrhosis based on the Stroop-CN model (NCRCID-CHESS 2106): a prospective multicenter study
• Discharge Outcomes of Hospitalized Patients with New Onset Decompensated Cirrhosis
• Effect of diabetes on mortality and liver transplantation in alcoholic liver cirrhotic patients with acute decompensation
• Effect of high versus standard protein provision on functional recovery in people with critical illness (PRECISe): an investigator-initiated, double-blinded, multicentre, parallel-group, randomised controlled trial in Belgium and the Netherlands
• Efficacy and safety of transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma-A systematic review and meta-analysis
• Elevated serum neurofilament light chain levels are associated with hepatic encephalopathy in patients with cirrhosis
• Entecavir vs. tenofovir disoproxil fumarate in the treatment of chronic hepatitis B patients with severe acute exacerbation
• Evaluating outcomes of transjugular intrahepatic portosystemic shunt procedure among Native Americans
• Extracellular Vesicles as Mediators of Neuroinflammation in Intercellular and Inter-Organ Crosstalk
• Frequency of Hypoglycemia in Cirrhotic Patients Undergoing Endoscopy
• Fructooligosaccharides reverses hepatic vascular dysfunction and dysbiosis in rats with liver cirrhosis and portal hypertension
• Full Outline of Unresponsiveness Score versus Glasgow Coma Scale in Predicting Clinical Outcomes in Altered Mental Status
• Genetically Modified Hepatocytes Targeting Bilirubin and Ammonia Metabolism for the Construction of Bioartificial Liver System
• Granulocyte colony stimulating factor improves Prednisolone responsiveness and 90-day survival in steroid eligible severe Alcohol associated Hepatitis: The GPreAH Study a randomized trial
• Gut Microbiota and Cytokine Profile in Cirrhosis
• Hepatic encephalopathy post-TIPS: Current status and prospects in predictive assessment
• Higher In-Hospital Mortality among Asian Americans Undergoing Transjugular Intrahepatic Portosystemic Shunt Procedure
• Hyperammonaemia: review of the pathophysiology, aetiology and investigation
• Impact of fecal microbiota transplantation in severe alcoholic hepatitis: A systematic review and meta-analysis
• Impacts of rifaximin and midodrine on morbidity, mortality, and quality of life in patients with decompensated liver cirrhosis
• Improvement in survival after transplantation for critically ill patients with cirrhosis in the United States
• Incidence and risk factors of acute kidney injury in cirrhosis: a systematic review and meta-analysis of 5,202,232 outpatients, inpatients and ICU-admitted patients
• Intestinal dysbacteriosis contributes to persistent cognitive impairment after resolution of acute liver failure
• Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine
• Liver transplantation in acute and acute-on-chronic liver failure
• Magnetic resonance imaging pattern recognition of metabolic and neurodegenerative encephalopathies in dogs and cats
• Malnutrition Severity Predicts Clinical Outcomes in Alcoholic Hepatitis: Evidence from National Data
• Medication burden and anticholinergic use are associated with overt HE in individuals with cirrhosis
• Membranoproliferative glomerulonephritis in a child with congenital portosystemic shunt
• Missense variant in PIGM associated with severe cystic encephalomalacia and portal vein thrombosis: Phenotypic and genotypic expansion of the glycosylphosphatidylinositol biosynthesis defect-1 (GPIBD1)
• Modulation of brain energy metabolism in hepatic encephalopathy: impact of glucose metabolic dysfunction
• Navigating Diagnostic Challenges: A Case of Acquired Hepatocerebral Degeneration Presenting as Worsening Hepatic Encephalopathy in Chronic Liver Disease
• Neurological recovery in rats with portocaval anastomosis-induced hepatic encephalopathy treated with leuprolide acetate, a GnRH agonist
• On-treatment decline in MELD score predicts one-month transplant-free survival in rodenticidal hepatotoxicity patients treated with low-volume plasma exchange
• Opsoclonus in Alcohol Withdrawal Syndrome with Chronic Liver Disease and Hepatic Encephalopathy
• Other causes of neurocognitive impairment than covert hepatic encephalopathy (CHE) are very frequent, either alone or associated with CHE, in cirrhotic patients with cognitive complaints
• Patient-Reported Outcome Screens for Cognitive Dysfunction and Predicts Admissions in Cirrhosis
• Pay attention to the diagnosis and treatment of "easily neglected" complications in liver cirrhosis
• Pediatric Perspectives on Liver Cirrhosis: Unravelling Clinical Patterns and Therapeutic Challenges
• Portal vein stenosis and hepatic encephalopathy induced by eosinophilic granulomatosis with polyangiitis
• Portosystemic Hepatic Encephalopathy Scores (PHES) differ between Danish and German healthy populations despite their geographical and cultural similarities
• Predicting the 28-day prognosis of acute-on-chronic liver failure patients based on machine learning
• Prescription patterns of statins in cirrhotic patients: a survey among primary care physicians and cardiologists
• Prevalence and Precipitants of Hepatic Encephalopathy in Hospitalized Children With Chronic Liver Disease
• Prevalence and prognosis of patients with MASLD-related cirrhosis after an ICU hospitalization in France: A single-centre prospective study
• Protective effect of menthol against thioacetamide-induced hepatic encephalopathy by suppressing oxidative stress and inflammation, augmenting expression of BDNF and alpha7-nACh receptor, and improving spatial memory
• Proton pump inhibitor use and risk of hepatic encephalopathy: A multicentre study
• Proton Pump Inhibitors in Patients with Cirrhosis: Pharmacokinetics, Benefits and Drawbacks
• Reply to: Does encephalopathy with early onset after TIPS impact on mortality?
• Response to "Brain Lesions in Liver Cirrhosis May Not Only Be Due to Hepatic Encephalopathy"
• Retraction Note: Amelioration of thioacetamide-induced hepatic encephalopathy in rats by low-dose gamma irradiation
• Retrospective Database Analysis of Liver-Related Clinical Events in Adult and Pediatric Patients with Alpha-1 Antitrypsin Deficiency in the United States
• Role of peripheral inflammation in minimal hepatic encephalopathy
• Serum Leucine Aminopeptidase Activity Patterns Across Various Disease States: Potential Implications for Bleeding and Thrombosis Risk
• Serum Prolactin as a Marker of the Severity of Liver Cirrhosis in a Tertiary Hospital in India: A Cross-Sectional Study
• Spleen volume is associated with overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with portal hypertension
• Stroop test, Quickstroop, and the 1-min animal naming test for minimal hepatic encephalopathy diagnosis: A multicenter study in Mexico
• Substitution of One Meat-Based Meal With Vegetarian and Vegan Alternatives Generates Lower Ammonia and Alters Metabolites in Cirrhosis: A Randomized Clinical Trial
• Symptom burden in chronic liver disease
• The causal effect of gut microbiota on hepatic encephalopathy: a mendelian randomization analysis
• The effect of rifaximin and lactulose treatments to chronic hepatic encephalopathy rats: An [(18)F]PBR146 in-vivo neuroinflammation imaging study
• The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints
• The social and psychological impact of hepatic encephalopathy
• The value of ammonia as a biomarker in patients with cirrhosis
• Therapeutic potential of rifaximin in liver diseases
• Thyroid storm with acute liver failure and disseminated intravascular coagulation- lessons in diagnosis and treatment
• Unveiling the protective potential of mirabegron against thioacetamide-induced hepatic encephalopathy in rats: Insights into cAMP/PPAR-gamma/p-ERK1/2/p S536 NF-kappaB p 65 and p-CREB/BDNF/TrkB in parallel with oxidative and apoptotic trajectories
• Vitamin D deficiency stratifies the risk of covert and overt hepatic encephalopathy in patients with cirrhosis: A retrospective cohort study
• When should a liver disease patient be admitted to the intensive care unit?